HCA Healthcare, Inc. (NYSE:HCA) Holdings Lowered by Compass Wealth Management LLC

Compass Wealth Management LLC trimmed its position in HCA Healthcare, Inc. (NYSE:HCA) by 3.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 15,146 shares of the company’s stock after selling 475 shares during the period. Compass Wealth Management LLC’s holdings in HCA Healthcare were worth $4,546,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Benjamin F. Edwards & Company Inc. acquired a new stake in HCA Healthcare in the 2nd quarter valued at about $33,000. Legacy Investment Solutions LLC acquired a new stake in HCA Healthcare during the third quarter valued at approximately $39,000. Canoe Financial LP bought a new position in shares of HCA Healthcare in the third quarter valued at $41,000. Capital Performance Advisors LLP bought a new stake in shares of HCA Healthcare during the 3rd quarter worth $41,000. Finally, Northwest Investment Counselors LLC purchased a new stake in shares of HCA Healthcare during the third quarter valued at $44,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Down 4.0 %

HCA opened at $312.51 on Friday. The firm has a market cap of $79.16 billion, a price-to-earnings ratio of 14.03, a PEG ratio of 1.09 and a beta of 1.64. HCA Healthcare, Inc. has a twelve month low of $279.93 and a twelve month high of $417.14. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The firm’s 50-day simple moving average is $313.49 and its 200-day simple moving average is $352.62.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 520.98% and a net margin of 8.52%. During the same period in the prior year, the company posted $5.90 EPS. Equities research analysts anticipate that HCA Healthcare, Inc. will post 21.75 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. Truist Financial reduced their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. StockNews.com cut shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Oppenheimer lifted their price target on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a report on Monday, October 28th. Morgan Stanley decreased their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 17th. Finally, Barclays dropped their price target on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a research report on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $385.27.

Insiders Place Their Bets

In other news, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares of the company’s stock, valued at $18,445,700. This represents a 6.89 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.